Partnering with the 3rd Next Generation RNA Therapeutics Summit was an opportunity to demonstrate your expertise, elevate your brand’s standing, and establish yourself as a key thought leader and front runner within the circular RNA, self-amplifying RNA and transfer RNA community.
With a wealth of investment, innovation and critical proof-of-concept data emerging from the next generation RNA space, and an ever-increasing number of companies launching new RNA medicines into discovery, pre-clinical and clinical studies, there was a unique opportunity for LNP formulators, enzyme suppliers, providers of plasmid DNAs, mRNA synthesis services and more to establish themselves as the go-to commercial partners for the industry.
This was your opportunity to communicate exciting progress to the decision-makers in the field, generate leads, and understand which tools and services the market wants and needs.
Recibiopharm
Expertise Partner
ReciBioPharm is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize advanced therapy medicinal products (ATMPs). ReciBioPharm’s specialized CDMO capabilities include pre-clinical to clinical and commercial development and manufacture for new biological modalities encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid-based mRNA and plasmid DNA production. Headed by a management team and technical experts with a proven track record in both process development and contract manufacturing, ReciBioPharm offers the knowledge and resources necessary to help customers develop and manufacture promising new therapies to meet the needs of patients across the world.
Lipoid
Expertise Partner
Since its foundation in 1977, Lipoid has gained an outstanding reputation in the development and industrial production of high-quality lecithin, phospholipids, and other lipid products, meeting the high standards of the pharmaceutical industry. Lipoid is the world’s leading company for the production and supply of a wide range of natural and synthetic phospholipid excipients on an industrial scale.
Virogin
Innovation Partner
Virogin Biotech is a clinical-stage immuno-oncology company which has developed two platforms: (1) HSV-1 based oncolytic virus and (2) mRNA-based (including saRNA) therapeutics, to elicit robust and durable anti-tumor immune response against solid tumors. We are developing saRNA platform as the next-gen technology with our 30 years of experience and know-hows in virology and immunology. We have developed multiple saRNA backbones optimized for different indications, along with a proprietary delivery system to support the development of both conventional and self-amplifying mRNA assets.
Norgen Biotek Corp
Exhibition Partner
Norgen Biotek Corp. is a fully-integrated biotechnology company based in Ontario, Canada,
renowned for its innovation and expertise in sample collection/preservation and isolation of
highly pure RNA, DNA, protein and exosomes. Norgen also offers solutions for molecular
diagnostics and NGS services such as small RNA-seq, including those for challenging samples.
Established in 1998 by Dr. Yousef Haj-Ahmad, Norgen has garnered global recognition within
the life sciences industry for providing reliable, high-quality products and services under
stringent ISO 9001 and ISO 13485 standards.
Chemgenes
Exhibition Partner
Established in 1981, ChemGenes has consistently provided the highest quality phosphoramidites and Solid Supports in the market. Our Massachusetts facility is setup for therapeutic grade phosphoramidites for GMP grade oligonucleotide manufacturing. Furthermore, ChemGenes carries the widest variety of modified phosphoramidites and solid supports currently used in various areas of Nucleic Acid research. ChemGenes remains devoted to providing you with invaluable customer service and comprehensive technical support.
Elevate Bio
Event Partner
ElevateBio is a technology-driven company powering transformative cell and gene therapies. The Company commercializes its technologies, manufacturing capabilities, and industry-leading expertise through partnerships to accelerate development across a breadth of therapeutic approaches and modalities. It combines multiple R&D technology platforms – including gene editing, cell engineering technologies, and viral and non-viral delivery – with BaseCamp®, its end-to-end process development and cGMP manufacturing business, to accelerate the discovery and development of advanced therapeutics
